• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • NMPA Temporary Rearrangements to Facilitate Registrations Affected by COVID-19

NMPA Temporary Rearrangements to Facilitate Registrations Affected by COVID-19

Tuesday, 12 May 2020 / Published in Medical Device

NMPA Temporary Rearrangements to Facilitate Registrations Affected by COVID-19

On 15.04.2020, the CMDE (Center for Medical Device Evaluation) of NMPA (National Medical Products Administration) announced (No.13-2020) temporary measures to rearrange the submission time and format of notarized documents for the applications of medical device registration affected by the COVID-19 outbreak.

Submission time for notarized documents

The NMPA has acknowledged that the outbreak of Covid-19 may present challenges for timely submission of documents from overseas. Therefore, in respect of any importing class II and III medical devices that are yet to submit the applications of product registration, change in registration, registration renewal, and clinical trials, the NMPA Legal Agent may proceed to submit any documents containing the signature of the overseas applicant first, whilst explaining the difficulties of the current situation in the CH1.11.5 section “Statement of authenticity and accuracy”, and stating that the NMPA Lega Agent will bear the corresponding legal responsibility for the authenticity and validity of the document yet to be notarized.

Form of notarized document submission

If overseas applicants and NMPA Legal Agents decide to handle NMPA medical device registration affairs online, they must submit an explanatory document to address the new notarized form in the CH1.11.5 section “Statement of authenticity and accuracy”.

Notarized documents meeting the above requirements will be accepted during the review process. The time to resume normal submission of notarized documents will be notified in accordance with the epidemic situation.

By Jacky Li. Contact Cisema to learn more.

Tagged under: COVID-19

What you can read next

Acceptance of Foreign Clinical Trial Data
New Top-Level China Medical Device/IVD Law “Order 739” Now In Force
China medical device mandatory standards list
China medical device mandatory standards list released in November 2022

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.